A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology

Grant

Date/time Interval

  • March 1, 2009 - September 29, 2012
  • Total Award Amount

  • 124850.00
  • Direct Costs

  • 103820.00
  • Sponsor Award Id

  • 2009
  • Contributor

  • Cantrell BSN, DNP, CRNP, Wendy   Investigator  
  • Elmets M.D., Craig   Principal Investigator